Safety study of KS101 in healthy volunteers
Part of Brain & nervous system, Kidney & urinary, Mental health, Women’s health & pregnancy clinical trials.
This study tests a new drug called KS101 to see if it is safe in healthy people. You will receive either a single dose or multiple doses of the drug, and doctors will watch for any side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy man or woman between 18 and 55 years old.
- You do not smoke or use nicotine, and have not for at least 32 months.
- You are not pregnant or breastfeeding, and will use reliable birth control if needed.
- You have no major medical conditions like heart disease, diabetes, or cancer.
- You are not taking any regular prescription medicines (except birth control or occasional pain relievers).
- You are willing to eat a high-fat meal and avoid grapefruit, caffeine, and alcohol during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests the safety of a new drug called KT-579 in healthy adults. It is the first time this drug is being given to humans. The study will help doctors understand how the drug works in the body and if it is safe.
This is an early-stage safety study testing a new tablet called KHN707 in healthy volunteers. Researchers want to understand how the body processes the drug and check for any side effects.
This trial is testing a new medicine called CKD-339 in healthy people to see how the body processes it and whether it is safe. It is an early-phase study, and participation can help determine if the drug is safe for future patients.
This trial tests a single dose of a new medication (NM-101) in healthy male volunteers to see how the body handles it and if it's safe. It is a phase 1 study that requires you to be in good health and have no major medical conditions.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
This trial tests a new medicine called AB102 in healthy people to see if it is safe and how the body processes it. It may help researchers understand the right dose for future studies.
Hear when a new Chronic kidney disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.